Abnormal change of p53 gene in gastric and precancerous lesions and APC gene deletion in gastric carcinoma and near tissues

Abstract

p53 gene mutation (exon4, 5, 6, 7, 8 and intron6) in gastric cancer and precancerous lesions and p53 gene(exon4 and ontron6), APC gene deletion in gastric carcinomas were studied by PCR/SSCP and PCR/RFLP. Results showed mutation rate of p53 in metaplasia, dysplasia and gastric carcinoma was 37. 5 % (3/8), 42.11 % (8/19), 53.33 (16/30) respectively. There was significant difference among groups of metaplasia, dysplasia, cancer and normal controls. No exon8 mutation was found in metaplasia and dysplasia, but 4 cases were found to have exon8 mutation in cancer group. It is suggested that exon8 mutation occurs at the late stage of gastric cancer, but exon 5,6,7 mutation occur in the course of precancerous lesion to cancer. Loss of heterozygosity (LOH) of exon4, intron6, APC was 47,37 % (9/19), 8.73% (2/23), 16.67 % (3/18) respectively. LOH of exon4 had something to do with poor differentiation, lymph node metastasis, depth of invasion. LOH of exon4 may be one of prognostic marker of gastric cancer. We are led to conclude that p53 gene mutation is an early event and perhaps work together with ras oncogene in gastric carcinogenesis

Keywords

p53 gene mutation / p53 gene deletion / APC gene deletion / gastric cancer / precancerous lesion

References

[1] LevineA J. Tumor suppressor genes, the cycle and cancer. Survey, 1992, 12: 1-1

[2] FriendS H. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcome. Nature, 1986, 323: 643-643

[3] MaoL, SidranskyD. Cancer screening based on genetic alterations in human tumors. Cancer Research, 1994, 54: 39s-39s

[4] BoyntonR F, BlountP L. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the major of human esophageal cancer. Proc Natl Acad Sci USA, 1992, 89: 3385-3385

[5] AshtonRickardt P G, WyllieA H, BirdCC, et al.. A candidate familial polyposis gene in 5q21 shows frequent allele loss in colorectal and lung cancer. Oncogene, 1991, 6: 1881-1881

[6] SanoT, TsujinoT, YoshidaK. Frequent loss of heterozygosity on chromosomes lq. 5q. and 17p in human gastric carcinomas. Cancer Research, 1991, 51: 2926-2926

[7] RhyuM G, ParkW S, JungY J. Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology, 1994, 106: 1584-1584

[8] HindsP, FinlayC, LevineA J. Mutation is required to activate the P53 gene for cooperate with ras oncoge transformation. J Virology, 1989, 63: 739-739

[9] NigroJ M, BakerS J, PreisingerA C, et al.. Mutations in the p53 gene in diverse human tumor type. Nature, 1989, 342: 705-705

[10] TamuraG, KihanaF, Nomurak, et al.. Detection of frequent p53 gene mutat ions in primary gastric cancer by cell sorting and PCR-SSCP. Cancer Research, 1991, 51(11): 3056-3056

[11] TohdoH, YokozakiH, HarumaK, et al.. gene mutation in gastric carcinoma. Virchows-Arch-B-Cell-Pathol-Incl-Mol-Pathol, 1993, 63(3): 191-191

[12] YokozakiH, KuniysuH, KitadaiY, et al.. point mutation in primary human gastric carcinomas. J Cancer Res Clin Oncol, 1992, 119(2): 67-67

[13] ShiaoY H, CorreaP. alteration in gastric precancerous lesions. Am J Pathology, 1994, 144(3): 511-511

[14] TharaE, YokocakH. Significance of p53 gene abnormalities in carcinog enesis of human gastrointestinal tract. Nippon Geka Gakkai Zasshi, 1992, 93(9): 940-940

[15] UchinoS, NoguchiM, OchiaiA. mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer, 1993, 54(5): 759-759

[16] ChoJ H, NoguchiM, OchiaiA. Analysis of regional differences of p53 mutation in advanced gastric carcinoma. Mod Pathol, 1994, 7(2): 205-205